Skip to content
Search

Latest Stories

UK launches study on virus spread in schools as ONS death tally set to cross 50,000

THE UK government has launched a study to find out the prevalence and spread of the coronavirus among school children and teachers in England on Tuesday (9) to help inform the phased reintroduction of education after a lengthy national lockdown.

The move came even as the government dropped plans for all primary schoolchildren to return for classes this month after initially announcing the move as part of the first phase in the coronavirus lockdown being lifted.


Education Secretary Gavin Williamson told the House of Commons that he wanted all children back to school in September, after summer break, and that "exams will take place next year".

"We are not able to welcome all primary for a full month before the summer," he added..

“We all know how important it is for children and young people to be in education and childcare and it is vital that we get them back there as soon as the scientific advice indicates that we can."

The decision to gradually re-open schools has divided opinion, with Britain suffering the second-worst international death toll from Covid-19 and ministers warning of the need for caution to prevent a second wave of the virus.

The study will look to establish how widespread the virus is among children, who typically show mild symptoms or no symptoms at all, and how effectively they transmit the disease.

"This study will help us better understand how common asymptomatic and mild cases of Covid-19 are so that we can support parents, pupils and teachers and support-staff, and inform our ongoing response to this new virus,” Health Secretary Matt Hancock said in a statement.

Selected age groups have been able to attend schools since the beginning of the month, although some educators decided not to re-open because they said it was not safe. Older students will also begin some schooling from June 15.

The voluntary study will be administered by the Public Health England agency and will collect data from around 200 staff and pupils at up to 100 English schools.

Researchers will use both swab tests - which check whether a person currently has the virus - and blood tests, which check whether the person has previously had the virus and developed antibodies to it.

Data will also be fed into wider government programmes designed to establish how widespread Covid-19 is, and has been, throughout the community in order to help form policy and develop new tests and treatments.

Earlier in the day, an analysis of official data said the number of suspected and confirmed deaths from coronavirus in Britain had risen to almost 50,000.

The Office for National Statistics figures tallied all fatalities in which Covid-19 was suspected or mentioned on death certificates up to May 29.

The total of 49,989 is higher than the government's latest daily figure of 40,597, which includes only the deaths of patients who tested positive for coronavirus.

The UK had announced 55 new deaths on Monday -- the lowest daily toll since March 22.

On either measure, the toll is Europe's worst and puts Britain behind only the US in officially announced deaths, although each country has different reporting methods and lag times.

The data also showed that deaths in England and Wales exceeded the average of the last five years by 57,961 in the 10-week period since the outbreak took hold in March.

Overall, an ONS expert said, about 64,000 more people than usual died in the UK during the pandemic.

Epidemiologists say excess mortality -- deaths from all causes that exceed the five-year average for the time of year -- is the best way of gauging the number to have died from a disease outbreak because it is internationally comparable.

More For You

Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less
chicken-pox-istock

The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)

iStock

England to introduce free chickenpox vaccine for children from 2026

CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.

GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.

Keep ReadingShow less
Naga Munchetty urges women to prioritise their health

Naga Munchetty

Naga Munchetty urges women to prioritise their health

WHEN broadcaster and journalist Naga Munchetty began speaking openly about her experiences with adenomyosis and debilitating menstrual pain, the response was overwhelming.

Emails and messages poured in from women who had endured years of dismissal, silence and shame when it came to their health. That outpouring became the driving force behind her new book, It’s Probably Nothing, which calls for women to be heard and to advocate for themselves in a medical system that has too often ignored them.

Keep ReadingShow less
London temple project for Shree Banke Bihari launched

London temple project for Shree Banke Bihari launched

Mahesh Liloriya

The Shree Kunj Bihari Vrindavan (UK) Temple has officially launched its project to establish a grand home for Shree Banke Bihari in London.

The inaugural event, held in Harrow from 4 pm, featured devotional chants, the Deep Pragtya ceremony, and a presentation outlining the temple’s vision. Speaking at the gathering, Shalini Bhargava described the planned temple as “a spiritual home promoting bhakti, unity and seva for generations to come.”

Keep ReadingShow less
Dickie and Watt

Dickie and Watt launched BrewDog at the age of 24

Getty Images

BrewDog co-founder Martin Dickie leaves after 17 years as James Watt steps back

Highlights:

  • Martin Dickie has announced his departure from BrewDog and the alcohol industry.
  • He co-founded the Ellon-based brewer with James Watt in 2007.
  • Dickie cited family time and personal reasons for his exit.
  • His departure follows recent bar closures as part of a company restructuring.
  • BrewDog confirmed no further leadership changes will follow.

BrewDog co-founder Martin Dickie has announced he is leaving the Scottish brewer and the wider alcohol industry for “personal reasons.” Dickie, who founded the Ellon-based business with James Watt in 2007, said he wanted to spend more time with his family after more than two decades in brewing and distilling.

Early beginnings

Dickie and Watt launched BrewDog at the age of 24, starting from a garage in Fraserburgh and selling hand-filled bottles from a van at local markets. The company grew rapidly to become one of the UK’s best-known craft brewers.

Keep ReadingShow less